The loss of federal funding from the Centers for Disease Control comes as Memphis health officials face rising rates of new ...

A former official at the Centers for Disease Control and Prevention warns that funding cuts outlined in the proposed fiscal ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, lenacapavir, as a tool in their efforts to fight HIV infections – especially for ...

Former CDC officials warn that proposed fiscal 2026 budget cuts would slash funding by 54%, threatening critical health ...

C ongress just passed a sweeping bill that includes changes to Medicaid expected to cut millions of people with low incomes ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

COVID paused prevention efforts, which helped fuel the rise in new infections. Now federal funding cuts threaten to disrupt ...

Increasing the use of Apretude among Black women requires not only expanding awareness of the long-acting PrEP regimen in ...